3 Ask about the CV indication or Bridge eligibility if weight-loss criteria are not met If your BMI is below 40 (California) or you cannot complete the Ozempic step (Northwest), ask your Kaiser provider whether the cardiovascular risk reduction indication applies
Third, discuss with your provider whether your current dose remains optimal or whether a slight adjustment, medication change, or combination therapy could help
It can help avoid type 2 diabetes, several cardiovascular diseases, some vision and kidney disorders and neurodegenerative diseases like Alzheimers disease
This might be seen as a network of evidence for the physiologic significance of the revealed BPC 157/NO-system interplay (i.e., BPC 157 was found in in situ hybridization and immunostaining studies in humans to be largely distributed in tissues [20] and may have additional physiologic regulatory roles [3,4,5,6,7,8,9,10,11,12,13,14,16,17,18,19,20,21,22,23,24,27,28,29,30,31,32,34,37,39,40])